EYDAP: RAB Assumptions Overly Optimistic

May 6th, 2026

Following on from our previous note on Dec 20th and the release of FY 2025 results, we now incorporate 2026–2029 RAB economics into our model. While EYDAP’s RAB assumptions appear robust on paper, we remain skeptical about their execution.

Greek Equities Briefing (Annual)

January 13th, 2025

This is our BoP Greek equities briefing. We have not made many changes compared to our semi-annual one in July: we downgraded Alpha and Helex; and upgraded Eurobank. Plus, we re-visited GEK, reiterating OI and replacing its soon-to-be-delisted RES subsidiary, Terna Energy.

EYDAP: Closer to RAB but Low Visibility Remains

October 1st, 2024

EYDAP reported disappointing Η1 2024 results which, once again, showcased the need for higher tariffs. Even though water consumption increased by +7.6% yoy and overall sales grew by +7.2%, clean EBIT (adjusted for litigation provisions) stood at E1.6m compared to E2.0m last year. EYDAP will be submitting its proposals to the regulator soon. We are bracing ourselves for…

EYDAP: Still Waiting For Higher Tariffs

April 27th, 2024

EYDAP reported FY 2023 results, above our estimates, for several reasons, some of which accounting in nature. The water utility remains a case study whereas a RAB model and higher tariffs remain the only catalyst for earnings (and dividends) to go sustainably higher. And for us to be able to put a target price on the equity.
Conclusion: In the meantime, we reiterate our DO NOT OWN IT (DOI) rating. Introducing a RAB model is as interesting as it is imperative. The lack of visibility remains on all fronts, namely tariffs, investment plan, capital structure and dividend policy.

EYDAP: Waiting For Higher Tariffs

October 2nd, 2023

H1 results did not bring anything new to the investment case. Water consumption moved further down, the non-invoiced part went up and EYDAP is still struggling to generate enough revenues to cover its (mainly) fixed cost base. EBIT was slightly negative (E0.3m). Not a reason to celebrate but adjusting for provisions, EBIT turns positive to E2.0m (from E1.1m in H1 2022). At least costs seem to have stabilized.